BiotechTube
Gene Universal

Gene Universal

Newark, United States· Est.
geneuniversal.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

Gene Universal operates as a specialized CRO and service provider in the genetics, genomics, and diagnostics sectors. Its core business model revolves around offering rapid, cost-effective, and reliable outsourced R&D services, such as gene synthesis for $49/construct and one-week recombinant antibody expression. The company appears to be in an early revenue-generating stage, leveraging a broad service portfolio to support client advancements in biotherapeutics, cell and gene therapy, and synthetic biology. Its strategic focus is on reducing time-to-market for clients through standardized, high-success-rate service packages.

Genetics & GenomicsDiagnostics

Technology Platform

Integrated suite of molecular biology service platforms for gene synthesis, protein/antibody expression, viral vector packaging, and custom assay development.

Funding History

1
Total raised:$3.5M
Seed$3.5M

Opportunities

Growing demand for outsourced R&D from virtual and biopharma companies creates a large addressable market.
Expansion into higher-margin, regulated services (GLP/GMP) and strategic partnerships with AI-driven drug discovery firms present significant growth avenues.
The global growth in cell/gene therapy and mRNA therapeutics directly drives demand for its viral packaging and synthesis services.

Risk Factors

Faces intense competition from large, established CROs and low-cost generic providers, risking price erosion.
Revenue is susceptible to downturns in biopharma R&D funding.
The business is highly reputation-dependent, making it vulnerable to any operational failures in service quality or timelines.

Competitive Landscape

Operates in a crowded CRO and life science tools market. Competitors range from global giants like Thermo Fisher Scientific and Charles River Labs to numerous niche players. Differentiation is based on speed, price, and guaranteed success rates rather than proprietary technology.

More companies in United States →